Immuneworks Llc

Immuneworks Llc

  • Ice Miller American Sq Ste 3100
  • Indianapolis, Indiana
  • 46282-0200

Description

ImmuneWorks, Inc is a biotechnology company developing novel therapeutics and diagnostic tests for patients with autoimmune conditions. Founded in 2006 by Indiana University School of Medicine researchers Drs. David Wilkes and Michael Klemsz on the principle of oral tolerance, ImmuneWorks’ expertise is their understanding of immunology and autoimmune diseases to create therapeutics that will make a difference in the lives of patients.

ImmuneWorks (www.immuneworks.com) is a biotechnology company developing novel therapeutics and diagnostic tests for patients with autoimmune conditions. Founded in 2006 by Indiana University School of Medicine researchers on the principle of oral tolerance, ImmuneWorks’ brings an understanding of immunology and autoimmune diseases to create therapeutics that will make a difference in the lives of patients.

As ImmuneWorks’ president and chief executive officer, Wade Lange is responsible for the company’s business strategy, operational effectiveness, strategic partnerships and financial viability. He has 30 years of experience in the pharmaceutical, healthcare and contract clinical research industry. Throughout his career, Mr. Lange has held a variety of executive leadership positions including president and CEO for Indiana Health Industry Forum, general manager for West Pharmaceutical Services, executive vice president for Walker Information and marketing professional for Eli Lilly and Company. As a seasoned life science and pharmaceutical industry expert, Mr. Lange has participated in and led strategic planning, market research, product development and clinical trial initiatives that have resulted in successfully commercialized drug products and company acquisitions. He received a bachelor’s degree in pharmacy from Purdue University and a master’s degree in industrial administration from the Krannert Graduate School of Management at Purdue.

We have created short videos for easy access and understanding of Idiopathic Pulmonary Fibrosis, our team, and the technology and business strategy that we are using to meet this need. Click on any of the pictures to learn more about us.

When Teresa Geiger attended a lung disease conference five years ago, she could count on one hand the number of meetings dedicated to something called idiopathic pulmonary fibrosis.

Products & services

Similar companies nearby